Published in:
Open Access
01-12-2015 | Oral presentation
Testosterone replacement in young male cancer survivors (TRYMS) - pragmatic adaptation of trial design for a trial struggling with recruitment
Authors:
Isabelle Smith, Jayne Swain, Helen Marshall, Alexandra Smith, Jennifer Walsh, Richard Ross, Sarah Brown
Published in:
Trials
|
Special Issue 2/2015
Login to get access
Excerpt
TRYMS is a multicentre, randomised, double-blinded, parallel group, placebo controlled phase IV trial in young male cancer survivors with low testosterone levels. The trial is designed to investigate whether testosterone treatment for 26 weeks will result in a reduction of truncal fat mass and increase in participant-reported physical functioning scores. …